Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model

Cytotherapy

Volumn 11, Issue 3, 2009, Pages 289-298

  Sun, Bo ^a   Roh, Kyoung Hwan ^a   Park, Jeong Ran ^a   Lee, Sae Rom ^a   Park, Sang Bum ^a   Jung, Ji Won ^a   Kang, Soo Kyung ^a   Lee, Yong Soon ^a   Kang, Kyung Sun ^a  

^a Seoul National University   (South Korea)

Author keywords

Adipose tissue; Breast cancer; Human umbilical cord blood; Mesenchymal stromal cells; Metastasis

Indexed keywords

CASPASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ADIPOSE TISSUE CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER STAGING; CELL HOMING; CELL ISOLATION; CELL TRANSPLANTATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LUNG METASTASIS; MESENCHYMAL STROMA CELL TRANSPLANTATION; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; TUMOR GROWTH; UMBILICAL CORD BLOOD;

EID: 68049124516     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240902807026     Document Type: Article

References (38)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
2. Strakova Z, Livak M, Krezalek M, Ihnatovych I. Multipotent properties of myofibroblast cells derived from human placenta. Cell and Tissue Research 2008;332:479-88.
3. Lin Y, Liu L, Li Z, Qiao J, Wu L, Tang W, et al. Pluripotency potential of human adipose-derived stem cells marked with exogenous green fluorescent protein. Molecular and Cellular Biochemistry 2006;291:1-10.
4. Sun B, Jeong Y-H, Jung J-W, Seo K, Lee Y-S, Kang K-S. Regulation of human umbilical cord blood-derived multipotent stem cells by autogenic osteoclast-based niche-like structure. Biochemical and Biophysical Research Communications 2007;357:92-8.
5. Kim JW, Kim SY, Park SY, Kim YM, Kim JM, Lee MH, et al. Mesenchymal progenitor cells in the human umbilical cord. Annals of Hematology 2004;83:733-8.
6. Laird DJ, von Andrian UH, Wagers AJ. Stem cell trafficking in tissue development, growth, and disease. Cell 2008;132:612-30.
7. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007;25:2739-49.
8. Ren C, Kumar S, Chanda D, Kallman L, Chen J, Mountz JD, et al. Cancer gene therapy using mesenchymal stem cells expressing interferon-[beta] in a mouse prostate cancer lung metastasis model. Gene Ther. 2008;15:1446-53.
9. Hsu WK, Wang JC, Liu NQ , Krenek L, Zuk PA, Hedrick MH, et al. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model. J Bone Joint Surg Am 2008;90:1043-52.
10. Finney MR, Greco NJ, Haynesworth SE, Martin JM, Hedreick DP, Swan JZ, et al. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia. Biology of Blood and Marrow Transplantation 2006;12:585-93.
11. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007;110:3499-506.
12. Lin T-M, Chang H-W, Wang K-H, Kao A-P, Chang C-C, Wen C-H, et al. Isolation and identification of mesenchymal stem cells from human lipoma tissue. Biochemical and Biophysial Research Communiations 2007;361:883-9.
13. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006;24:1294-301.
14. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Experimental Hematology 2005;33:1402-16.
15. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001;1:46-54.
16. Park CC, Bissell MJ, Barcellos-Hoff MH. The influence of the microenvironment on the malignant phenotype. Mol Med Today 2000;6:324-9.
17. Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 2006;203:1235-47.
18. Ren C, Kumar S, Chanda D, Chen J, Mountz JD, Ponnazhagan S. Therapeutic potential of mesenchymal stem cells producing IFN-a in a mouse melanoma lung metastasis model. Stem Cells 2008;26:2332-8.
19. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449:557-63.
20. Chang Y-J, Shih DT-b, Tseng C-P, Hsieh T-B, Lee D-C, Hwang S-M. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 2006;24:679-85.
21. Park J-R, Jung J-W, Lee Y-S, Kang K-S. The roles of wnt antagonists dkk1 and sfrp4 during adipogenesis of human adipose tissue-derived mesenchymal stem cells. Cell Proliferation 2008;41:859-74.
22. Ghodsizad A, Niehaus M, Koegler G, Martin U, Wernet P, Bara C, et al. Transplanted human cord blood derived unrestricted somatic stem cells improve left-ventricular function and prevent left-ventricular dilation and scar formation after acute myocardial infarction. Heart 2009;95:27-35.
23. Wang M, Yang Y, Yang D, Luo F, Liang W, Guo S, et al. The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 2008;126:220-32.
24. Kim J-M, Lee S-T, Chu K et al. Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res 2007;1183:43-50.
25. Sasser AK, Bethany LM, Kristen MS et al. Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3d tumor environments. Cancer Lett 2007;254:255-64.
26. Zhu W, Xu W, Jiang R et al. Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol 2006;80:267-74.
27. Lazennec G, Jorgensen C. Concise review. Adult multipotent stromal cells and cancer: Risk or benefit? Stem Cells 2008;26: 1387-94.
28. Hurst DR, Welch DR. A msc-ing link in metastasis? Nat Med 2007;13:1289-91.
29. Maestroni GJM, Hertens E, Galli P. Factor(s) from nonmacrophage bone marrow stromal cells inhibit lewis lung carcinoma and b16 melanoma growth in mice. Cell Mol Life Sci 1999;55:663-7.
30. Ohlsson LB, Varas L, Kjellman C et al. Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Exp Mol Pathol 2003;75:248-55.
31. Komarova S, Kawakami Y, Stoff-Khalili MA et al. Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol Cancer Ther 2006;5:755-66.
32. Studeny M, Marini FC, Champlin RE et al. Bone marrowderived mesenchymal stem cells as vehicles for interferon-β delivery into tumors. Cancer Res 2002;62:3603-8.
33. Studeny M, Marini FC, Dembinski JL et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeteddelivery vehicles for anticancer agents. J Natl Cancer Inst 2004;96:1593-603.
34. Kucerova L, Altanerova V, Matuskova M et al. Adipose tissuederived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 2007;67:6304-13.
35. Kyriakou CA, Yonk KL, Benjamin R, Pizzey A, Dogan A, Singh N, et al. Human mesenchymal stem cells (hmscs) expressing truncated soluble vascular endothelial growth factor receptor (tsflk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model. The Journal of Gene Medicine 2006;8:253-64.
36. Gunn WG, Conley A, Deininger L et al. A crosstalk between myeloma cells and marrow stromal cells stimulates production of dkk1 and interleukin-6: A potential role in the development of lytic bone disease and tumor progression in multiple myeloma. Stem Cells 2006;24:986-91.
37. Sasser AK, Sullivan NJ, Studebaker AW et al. Interleukin-6 is a potent growth factor for ER-a-positive human breast cancer. FASEB J 2007;21:3763-70.
38. Ramasamy R, Lam EWF, Soeiro I et al. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: Impact on in vivo tumor growth. Leukemia 2006;21:304-10.